Skip to main content
. 2020 Oct 14;42(7):1171–1179. doi: 10.1038/s41401-020-00543-x

Fig. 3. Expression of FOXC1 was associated with a poor prognosis in breast cancer patients.

Fig. 3

a Patients with high FOXC1 expression had a lower overall survival rate than patients with low FOXC1 expression (in silico analysis) (log-rank P < 0.05). b Analysis of clinical data showed that breast cancer patients with high FOXC1 expression had a lower overall survival rate than patients with low FOXC1 expression (P = 0.0004).